The global anesthesia endotracheal tubes market size reached US$ 173.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 238.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.
Anesthesia endotracheal tubes (ETTs) are used for intubation and manufactured using a polyvinylchloride (PVC) tube, which is inserted into the trachea and allows direct delivery of oxygen (O2) and removal of carbon dioxide (CO2) from the lungs. They aid in maintaining the airway passage of the lungsand allowing mechanical ventilation. They are also utilizedfor protecting the lungs from contamination of gastric contents and nasopharyngeal matter and during intermittent positive pressure ventilation (IPPV), resuscitation, Diptheria, epiglottis, and direct suctioning of the trachea in meconium aspiration. They enable healthcare professionals to sedate the patient and performing the surgical procedure. As a result, ETTsare widely used in surgery centers, trauma centers, and intensive care units (ICUs).
Anesthesia Endotracheal Tubes Market Trends:
The increasing prevalence of chronic disorders and viral infections among the masses, especially the geriatric population, which is more susceptible to thesemedical ailments, represents one of the major factors positively influencing the demand for anesthesia ETTs worldwide. In addition, the rising number of fatal road accidents and the growing number of trauma cases are driving the market. Apart from this, key players are introducing anesthesia ETTs with flexible tips that offer enhanced comfort and convenience to the users and assist in navigating through fragile airways with minimal discomfort. Furthermore, the escalating number of smokers and alcohol consumers is contributing to the market growth. Moreover, increasing incidences of airborne diseases on account of the rising air pollution arecreating a positive outlook in the market. Besides this, the expanding investments in improving healthcare infrastructure and medical services are projected to offer lucrative growth opportunities to industry investors.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia endotracheal tubes market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on, intubation type, product type, and end user.
Breakup by Intubation Type:
Nasotracheal intubation dominates the market as it is easier to secure, moves less, minimizes the risk of trauma to lips, tongue, and larynx, and provides comfort to patients.
Breakup by Product Type:
- Regular Tubes
- Reinforced/Armored Tubes
- Coated Tubes
Coated tubes currently dominate the market.
Breakup by End User:
- Ambulatory Surgery Centers
Anesthesia endotracheal tubes are extensively used in hospitals as it is an emergency procedure performed on people to maintain an open airway and help prevent suffocation.
Breakup by Region:
- North America
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
North America holds the majority of the global anesthesia endotracheal tubes market share due to the increasing prevalence of severe chronic ailments among the masses of the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.
|Base Year of the Analysis
||Intubation Type, Product Type, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)